DUBLIN, Nov. 11, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/jd86lr/continuous_renal) has announced the addition of the "Continuous Renal Replacement Therapy (CRRT) Market by Products (System, Disposables (Hemofilters & Bloodlines), & Dialysate/Replacement Fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF) and Geography - Regional Adoption and Global Forecasts to 2020" report to their offering.
The market is expected to reach USD 1.1 Billion by 2020 at CAGR of 7.2% from 2015 to 2020
This report studies the global continuous renal replacement therapy market over the forecast period of 2015 to 2020. A number of factors such as the rising prevalence of AKI, increasing prevalence of sepsis, growing number of ICU patients, clinical advantages of CRRT over intermittent blood purification techniques, technological advancements in CRRT systems, and the preference for CRRT (it is held as the gold standard for the treatment of hemodynamically unstable patients) are propelling the growth of the CRRT market.
However, the high complexity of therapy, high procedural cost of CRRT, dearth of trained ICU nurses, and stringent and regulatory guidelines for CRRT in North America are factors restraining the growth of this market. Poor reimbursement scenarios in developing nations, a lack of substantial clinical evidence supporting the efficacy of CRRT, and inadequacy of currently approved CRRT technology for children are the key challenges faced by market players in the continuous renal replacement therapy market.
Product approvals, launches, and enhancements are the key strategies adopted by major players to strengthen their positions in the global continuous renal replacement therapy market. Moreover, strategies such as acquisition, expansion, and agreements, partnerships, and collaborations were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the market.
Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), Bellco S.r.l. (Italy), Fresenius Medical Care AG & Co. KGaA (Germany), Infomed SA (Switzerland), Medica S.p.A (Italy), Medical Components, Inc. (U.S.), Nikkiso Co., Ltd (Japan), NxStage Medical, Inc. (U.S.), and Toray Medical Company Limited (Japan) are the key players operating in the global continuous renal replacement therapy market.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Adoption of CRRT, by Region
8 CRRT Market, by Product
9 CRRT Market, by Modality
10 CRRT Market, by Region
11 Competitive Intelligence Analysis
12 Company Profiles
For more information visit http://www.researchandmarkets.com/research/jd86lr/continuous_renal
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets